logo

For the Inventor, By the Inventor

Fresnes, France

Sylvie Wentzler

This inventor holds 7 USPTO granted patents and 1 published patent application. Top assignee: Aventis Pharma S.a.. Active years: 2003-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sylvie Wentzler. Retrieved from https://idiyas.com/inventor/sylvie-wentzler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 14.3

Average Co-Inventor Count = 6.4

ph-index = 2

Forward Citations = 22(Granted Patents)


Location History:

  • L'Hay les Roses, FR (2010)
  • Fresnes, FR (2003 - 2011)

Company Filing History:

goldMedal7 out of 377 
 
Aventis Pharma S.a.
 patents

Years Active: 2003-2011

Loading Chart...
7 patents (USPTO):Explore Patents
1. 7968566 - Pyrrolo(2,3-b) pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors (2011-06-28),
2. 7786114 - Bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors (2010-08-31),
3. 7528147 - Pyrrolo (2,3-b)pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors (2009-05-05),
4. 7148215 - Chemical compounds (2006-12-12),
5. 7119115 - Indazole or indole derivatives, and use thereof in human medicine and more particularly in oncology (2006-10-10),
6. 6566362 - Benzo[f]naphthyridine derivatives, their preparation and compositions containing them (2003-05-20),
7. 6548506 - Benzo[1,8]naphthyridine derivatives, their preparation and pharmaceutical compositions which comprise them (2003-04-15),

Title: Sylvie Wentzler: Innovator in Pharmaceutical Chemistry

Introduction

Sylvie Wentzler is a notable inventor based in Fresnes, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of kinase inhibitors. With a total of 7 patents to her name, Wentzler's work has the potential to impact various therapeutic areas.

Latest Patents

Wentzler's latest patents include innovative compounds such as pyrrolo(2,3-b) pyridine derivatives, which are designed for pharmaceutical use as kinase inhibitors. These compounds are characterized by specific formulas and are intended for use in treating diseases related to protein kinases. Another significant patent involves bis-azaindole derivatives, which also serve as kinase inhibitors, showcasing her expertise in creating novel pharmaceutical compositions.

Career Highlights

Throughout her career, Wentzler has been associated with Aventis Pharma S.A., where she has played a crucial role in advancing pharmaceutical research. Her work has not only contributed to the scientific community but has also paved the way for new treatment options in medicine.

Collaborations

Wentzler has collaborated with esteemed colleagues such as Conception Nemecek and Corinne Venot, further enhancing her research and development efforts in the pharmaceutical industry.

Conclusion

Sylvie Wentzler's innovative contributions to pharmaceutical chemistry, particularly in the realm of kinase inhibitors, highlight her as a key figure in the field. Her patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…